Table 1. Characteristics of 158 elderly participants included in the active surveillance of adverse events following the COVID-19 inactivated vaccine (CoronaVac). Sao Paulo, February to April 2021.
| Characteristic | |
|---|---|
| Age (years) | |
| Min.-Max. | 65 – 101 |
| Median | 83.00 |
| Mean ± Std. Dev. | 84.09 ± 5.75 |
| Gender (n=158) | |
| Female | 101 (63.92) |
| Skin color (n=155) | |
| White | 114 (73.55) |
| Black / Mixed ethnicity | 35 (22.58) |
| Asian | 5 (3.23) |
| Indigenous | 1 (0.65) |
| Not informed | 3 (1.94) |
| Comorbidity | |
| At least one | 151 (95.57) |
| None | 3 (1.90) |
| Not informed | 4 (2.53) |
| Arterial hypertension | 95 (60.13) |
| Cardiopathy | 52 (32.91) |
| Dyslipidemia | 40 (25.32) |
| Diabetes mellitus | 36 (22.79) |
| Hypothyroidism | 26 (16.46) |
| Neoplasms | 21(13.29) |
| Alzheimer’s disease / Other dementia | 14 (9.43) |
| Immune-mediated inflammatory diseases | 15 (9.43) |
| Chronic lung disease | 12 (8.86) |
| Chronic kidney disease | 13 (8.23) |
| Osteoporosis | 9 (5.70) |
| Neurologic / Psychiatric disease | 9 (5.70) |
| Obesity | 7 (4.43) |
| Other* | 22 (13.92) |
| Immunosuppressive therapy | 8 (5.03) |
| Katz IADL** | |
| Independent | 117 (74.05) |
| Moderate impairment | 12 (7.59) |
| Severe Impairment | 22 (13.92) |
| Not evaluated | 7 (0.44) |
| SOF*** Frailty Index | |
| Robust | 66 (41.77) |
| Prefrail | 54 (34.18) |
| Frail | 31 (19.62) |
| Not evaluated | 7 (0.44) |
*HIV/AIDS (3), depression (3), adrenal insufficiency (2), labyrinthitis (2), macular degenerative disease (2), aorta aneurysm (2), Chagas disease (2), pulmonary tuberculosis (1), sickle cell anemia (1), hyperthyroidism (1), thyroid nodule (1), pemphigus (1), liver transplantation (1); **Katz IADL – Katz Index of Independence in Activities of Daily Living; ***SOF – Study of Osteoporotic Fractures.